title: In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular events in high-risk patients: lessons learned from the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects Wtih Cardiovascular Disease (TRANSCEND).
authors.affiliation: Division of General Internal Medicine, University of Nevada School of Medicine, Reno, NV, USA. mbloch@aol.com
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Bloch
authors.forename: Jan N
authors.initials: JN
authors.lastname: Basile